The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-6-(4-Hydroxypiperidin-1-yl)-2-(1,3,6-trimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione ID: ALA4065133
PubChem CID: 130471723
Max Phase: Preclinical
Molecular Formula: C27H26N4O4
Molecular Weight: 470.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2c(cc1N1C(=O)c3cccc4c(N5CCC(O)CC5)ccc(c34)C1=O)n(C)c(=O)n2C
Standard InChI: InChI=1S/C27H26N4O4/c1-15-13-22-23(29(3)27(35)28(22)2)14-21(15)31-25(33)18-6-4-5-17-20(30-11-9-16(32)10-12-30)8-7-19(24(17)18)26(31)34/h4-8,13-14,16,32H,9-12H2,1-3H3
Standard InChI Key: LLHGUSJJGJYSJO-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 40 0 0 0 0 0 0 0 0999 V2000
34.6485 -10.5874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0757 -10.5839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3604 -10.1747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6474 -11.4148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9346 -11.8273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9353 -12.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6549 -13.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3622 -11.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3623 -12.6456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0668 -13.0522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7756 -12.6455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7756 -11.8275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0665 -11.4164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4861 -13.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4837 -13.8844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1967 -14.2977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1974 -12.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9112 -13.0568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9157 -13.8857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7055 -14.1376 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.1891 -13.4642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6981 -12.7963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.4903 -11.4156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.0656 -13.8772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.9486 -12.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9648 -14.9207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0141 -13.4596 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.7682 -14.2952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2197 -11.4155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2242 -10.5883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5134 -10.1766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7969 -10.5863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7957 -11.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5111 -11.8286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0836 -10.1718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
13 2 1 0
2 3 2 0
3 1 1 0
8 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 9 2 0
8 9 1 0
8 13 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 2 0
15 16 1 0
16 19 2 0
18 17 2 0
17 14 1 0
11 14 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
12 23 2 0
10 24 2 0
22 25 1 0
20 26 1 0
21 27 2 0
15 28 1 0
5 29 1 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
32 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 470.53Molecular Weight (Monoisotopic): 470.1954AlogP: 3.10#Rotatable Bonds: 2Polar Surface Area: 87.78Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.23CX LogP: 2.77CX LogD: 2.77Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.46Np Likeness Score: -0.82
References 1. Bouché L, Christ CD, Siegel S, Fernández-Montalván AE, Holton SJ, Fedorov O, Ter Laak A, Sugawara T, Stöckigt D, Tallant C, Bennett J, Monteiro O, Díaz-Sáez L, Siejka P, Meier J, Pütter V, Weiske J, Müller S, Huber KVM, Hartung IV, Haendler B.. (2017) Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains., 60 (9): [PMID:28402630 ] [10.1021/acs.jmedchem.7b00306 ]